Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial.
Saved in:
| Title: | Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial. |
|---|---|
| Authors: | Blauvelt A; Oregon Medical Research Center, Portland., Teixeira HD; AbbVie Inc, North Chicago, Illinois., Simpson EL; Department of Dermatology, Oregon Health & Science University, Portland., Costanzo A; Dermatology Unit, Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.; Humanitas Clinical and Research Center, Scientific Institute for Research, Hospitalization and Healthcare, Rozzano, Italy., De Bruin-Weller M; Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, the Netherlands., Barbarot S; Department of Dermatology, Nantes Université, Centre Hospitalier Universitaire de Nantes, Nantes, France., Prajapati VH; Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.; Division of Community Pediatrics, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada.; Division of Pediatric Rheumatology, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada.; Skin Health & Wellness Centre, Calgary, Alberta, Canada.; Dermatology Research Institute, Calgary, Alberta, Canada.; Probity Medical Research, Calgary, Alberta, Canada., Lio P; Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.; Medical Dermatology Associates of Chicago, Chicago, Illinois., Hu X; AbbVie Inc, North Chicago, Illinois., Wu T; AbbVie Inc, North Chicago, Illinois., Liu J; AbbVie Inc, North Chicago, Illinois., Ladizinski B; AbbVie Inc, North Chicago, Illinois., Chu AD; AbbVie Inc, North Chicago, Illinois., Eyerich K; Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.; Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany. |
| Source: | JAMA dermatology [JAMA Dermatol] 2021 Sep 01; Vol. 157 (9), pp. 1047-1055. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN: 2168-6084 (Electronic) Linking ISSN: 21686068 NLM ISO Abbreviation: JAMA Dermatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
